What is the current Price Target for the Co-Diagnostics, Inc. stock?

The average Co-Diagnostics, Inc. target price is $1.00. This is 209.60% higher than the current stock price. 1 Analyst has issued a Co-Diagnostics, Inc. price target 2026.

How high will the Co-Diagnostics, Inc. stock rise?

No reliable answer can be given as to how high the Co-Diagnostics, Inc. stock will rise. The performance of stocks, including the Co-Diagnostics, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Co-Diagnostics, Inc. stock today?

The performance of Co-Diagnostics, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Co-Diagnostics, Inc. stock fall?

The decline in Co-Diagnostics, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Co-Diagnostics, Inc. Forecast, price target & analysts

$0.32

1.11% today

Nasdaq, Apr 04, 07:16 pm CET

ISIN

US1897631057

Symbol

CODX

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Co-Diagnostics, Inc. Target price 2025 - Analyst rating & recommendation

Co-Diagnostics, Inc. Classifications & Recommendation:

Hold

100%

Co-Diagnostics, Inc. Price Target

Target Price	$1.00
Price	$0.32
Potential	209.60% register free of charge
Number of Estimates	1

	1 Analyst has issued a Co-Diagnostics, Inc. price target 2026. The average Co-Diagnostics, Inc. target price is $1.00. This is 209.60% register free of charge higher than the current stock price.
	A rating was issued by 1 analysts: 0 Analysts recommend Co-Diagnostics, Inc. to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Co-Diagnostics, Inc. stock has an average upside potential 2026 of 209.60% register free of charge . Most analysts recommend the Co-Diagnostics, Inc. stock at Hold.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Revenue Million $	0.77	1.50
	22.22%	94.81%

1 Analyst has issued a sales forecast Co-Diagnostics, Inc. 2025 . The average Co-Diagnostics, Inc. sales estimate is

Unlock

. This is

Unlock

than the revenue of the last 12 months(TTM). The highest sales forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics:

2024	$770k	22.22%
2025	$1.5m 94.81% Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '24	2025 Estimates
EV/Sales		negative

Based on analysts' sales estimates for 2025, the Co-Diagnostics, Inc. stock is valued at an EV/Sales of

Unlock

and an P/S ratio of

Unlock

This results in the following potential growth metrics and future valuations:

Current	-21.77	620.86%
2025	-11.17 48.68% Unlock

Current	14.08	173.84%
2025	7.23 48.67% Unlock

Co-Diagnostics, Inc....

Current Co-Diagnostics, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Mar 28 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Nov 11 2024

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Mar 28 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Nov 11 2024

Discover more stocks with a high price target

Novo Nordisk 83.92%

Coinbase Global, Inc. 83.53%

BioNTech SE - ADR 50.09%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now